Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaccine- and Infection-derived Correlates of Protection for Cholera
NCT06455852Recruiting
- Sponsor
- Massachusetts General Hospital
- Start
- Mar 2025
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Randomised trial in cholera (2 arms), sponsored by Massachusetts General Hospital. Primary endpoint: Vibrio cholerae infection at 2 years. Started Mar 2025; status: recruiting.
02
Conditions
cholera
Beyond the preview
Go deeper on NCT06455852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06455852.